News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,622 Results
Type
Article (49415)
Company Profile (278)
Press Release (678929)
Section
Business (212141)
Career Advice (2093)
Deals (36518)
Drug Delivery (98)
Drug Development (83499)
Employer Resources (170)
FDA (16925)
Job Trends (15685)
News (358931)
Policy (34627)
Tag
Academia (2759)
Alliances (51468)
Alzheimer's disease (1352)
Approvals (16890)
Artificial intelligence (202)
Bankruptcy (366)
Best Places to Work (12086)
Biotechnology (191)
Breast cancer (224)
Cancer (1654)
Cardiovascular disease (130)
Career advice (1754)
Cell therapy (331)
Clinical research (66992)
Collaboration (636)
Compensation (333)
COVID-19 (2684)
C-suite (152)
Data (1540)
Diabetes (203)
Diagnostics (6452)
Earnings (87286)
Employer resources (147)
Events (115561)
Executive appointments (548)
FDA (17781)
Funding (575)
Gene therapy (229)
GLP-1 (687)
Government (4622)
Healthcare (19829)
Infectious disease (2790)
Inflammatory bowel disease (119)
Interviews (317)
IPO (16795)
Job creations (4041)
Job search strategy (1498)
Layoffs (448)
Legal (8432)
Lung cancer (247)
Manufacturing (229)
Medical device (14246)
Medtech (14251)
Mergers & acquisitions (20043)
Metabolic disorders (551)
Neuroscience (1758)
NextGen: Class of 2025 (6907)
Non-profit (4734)
Northern California (1963)
Obesity (317)
Opinion (204)
Parkinson's disease (118)
Patents (140)
People (59588)
Phase I (20839)
Phase II (29441)
Phase III (21989)
Pipeline (656)
Postmarket research (2740)
Preclinical (8848)
Radiopharmaceuticals (250)
Rare diseases (311)
Real estate (6291)
Regulatory (23256)
Research institute (2473)
Resumes & cover letters (359)
Southern California (1701)
Startups (3822)
United States (17851)
Vaccines (636)
Weight loss (227)
Date
Today (170)
Last 7 days (624)
Last 30 days (2912)
Last 365 days (35526)
2025 (3050)
2024 (36108)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55915)
2019 (48798)
2018 (36939)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (791)
Arizona (214)
Asia (40602)
Australia (6692)
California (4512)
Canada (1632)
China (382)
Colorado (211)
Connecticut (224)
Europe (87837)
Florida (651)
Georgia (164)
Illinois (474)
Indiana (255)
Maryland (739)
Massachusetts (3511)
Michigan (196)
Minnesota (338)
New Jersey (1286)
New York (1298)
North Carolina (865)
Northern California (1963)
Ohio (165)
Pennsylvania (1047)
South America (1182)
Southern California (1701)
Texas (662)
Utah (134)
Washington State (455)
728,622 Results for "alucent medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Alucent Biomedical Receives Regulatory Approval for Second U.S. Clinical Study
Alucent Biomedical Inc. announced that the U.S. Food & Drug Administration granted an Investigational Device Exemption for a U.S. clinical study of its AlucentNVS technology for promoting the maturation of arteriovenous fistulas in patients requiring hemodialysis.
November 7, 2023
·
2 min read
FDA
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
Alucent Biomedical Inc. today announced that the U.S. Food & Drug Administration granted an Investigational Device Exemption (IDE) for a U.S. clinical study of AlucentNVS, a unique light-activated, drug-coated balloon catheter technology.
August 2, 2023
·
1 min read
Press Releases
AI/ML Innovations Inc. Appoints Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships
January 27, 2025
·
3 min read
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
January 27, 2025
·
2 min read
Press Releases
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
January 8, 2025
·
7 min read
Press Releases
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
January 15, 2025
·
1 min read
Press Releases
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
January 17, 2025
·
6 min read
Alucent Biomedical Announces First Patient Enrolled in the First-in-Human Clinical Trial of Its Novel AlucentNVS Technology for Arteriovenous Fistula (AVF) in People with End Stage Renal Disease (ESRD)
Alucent Biomedical Inc., a company dedicated to developing and commercializing its breakthrough AlucentNVS technology for the treatment of vascular disease, announced today that it has enrolled the first patient in ACTIVATE AVF, a safety and feasibility study of AlucentNVS for arteriovenous fistula (AVF) in people with end stage renal disease (ESRD).
January 9, 2023
·
2 min read
Press Releases
CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer
December 30, 2024
·
3 min read
1 of 72,863
Next
